High expression of MTHFR was associated with shorter BCR-free survival (p = 0.020; Figure 2C) and shorter prostate cancer-specific survival (p = 0.002; Figure 2D) in two independent datasets [8,9]. Here, MTHFR is linked to prostate carcinoma.